BD Completes Spin-Off of Biosciences & Diagnostic Solutions Business, Announces $4B Cash Proceeds for Buybacks & Debt Repayment

summarizeSummary

Becton Dickinson completed the spin-off of its Biosciences & Diagnostic Solutions business, receiving $4 billion in cash. The company plans to use these proceeds for a $2 billion accelerated share repurchase program and $2 billion in debt repayment.

check_boxKey Events

• Spin-Off Completion

  Becton Dickinson successfully completed the previously announced spin-off of its Biosciences & Diagnostic Solutions business and its combination with Waters Corporation on February 9, 2026.

• Significant Cash Proceeds

  BD received $4 billion in cash from SpinCo as part of the transaction.

• Capital Allocation Plan

  The company expects to use $2 billion of the cash proceeds for an accelerated share repurchase program and the remaining $2 billion for debt repayment, both in the near term subject to market conditions.

• Shareholder Distribution

  BD shareholders received approximately 0.135 shares of Waters common stock for each BD common stock held as of the February 5, 2026 record date, representing 39.2% of the combined Waters company.

auto_awesomeAnalysis

This filing marks the completion of a significant strategic transformation for Becton Dickinson, positioning it as a pure-play MedTech company. The receipt of $4 billion in cash from the spin-off provides substantial financial flexibility. The planned allocation of these funds—$2 billion for an accelerated share repurchase program and $2 billion for debt repayment—is a strong positive signal to investors. Share repurchases can boost earnings per share and return capital to shareholders, while debt reduction strengthens the balance sheet and lowers financial risk. The transaction, which valued the spun-off business at $18.8 billion, allows BD to focus on its "Excellence Unleashed" strategy, emphasizing differentiated innovation and operational efficiency in its core medical technology segments. The change in board composition is a direct consequence of this strategic realignment.